A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
Clinical trial NCT05960097 · COMPLETED
Trial details
- NCT number
- NCT05960097
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-08-30
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.